Product image of Glimepirid Bluefish (Glimepiride) supplied by GNH India

Glimepirid Bluefish

Active Ingredient:
Glimepiride
Origin:
EU

Glimepirid Bluefish (Glimepiride)

Glimepirid Bluefish is a prescription oral medication containing the active ingredient glimepiride, a sulfonylurea used for the management of type 2 diabetes mellitus. It belongs to the antidiabetic (oral hypoglycemic) therapeutic class and works by stimulating insulin release from pancreatic beta cells. The product is marketed in the European Union and is supplied in tablet form, although specific strength information is not disclosed.

Manufacturer / TM Owner

Bluefish Pharmaceuticals Ab

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Glimepirid Bluefish is indicated for adults with type 2 diabetes mellitus when diet, exercise, and other oral agents do not provide adequate glycemic control.

  • Improves fasting and post‑prandial blood glucose levels.
  • Used as monotherapy or in combination with other antidiabetic agents.
  • May be added when metformin alone is insufficient.
  • Helps achieve individualized HbA1c targets.
  • Suitable for patients who can tolerate sulfonylureas.

Side Effects

Glimepirid Bluefish may cause a range of side effects, most of which are mild and transient. Serious adverse reactions are less common but require prompt medical attention.

Common

  • Hypoglycemia (low blood sugar)
  • Weight gain
  • Nausea or abdominal discomfort
  • Headache
  • Dizziness
  • Skin rash or itching

Serious

  • Severe hypoglycemia with loss of consciousness
  • Allergic reactions such as angioedema or anaphylaxis
  • Hepatic dysfunction
  • Hematologic abnormalities (e.g., leukopenia)

Precautions & Warnings

Before starting Glimepirid Bluefish, certain precautions should be considered to minimize risks and ensure safe use.

  • Assess renal and hepatic function prior to initiation.
  • Use cautiously in elderly patients due to increased hypoglycemia risk.
  • Monitor blood glucose regularly, especially when adjusting dose.
  • Avoid use in patients with known sulfonylurea hypersensitivity.
  • Counsel patients on recognizing and managing hypoglycemia.
  • Review concomitant medications that may affect glucose levels.

Avoid Interactions

Glimepirid Bluefish can interact with several drug classes, influencing its efficacy or safety profile. Some combinations should be avoided, while others require careful monitoring.

Avoid

  • Other sulfonylureas or insulin secretagogues (risk of additive hypoglycemia).
  • Strong CYP2C9 inhibitors such as fluconazole or amiodarone (may increase glimepiride levels).
  • High‑dose salicylates (enhanced hypoglycemic effect).

Use with caution

  • Beta‑blockers (may mask hypoglycemia symptoms).
  • Thiazide diuretics (potential for altered glucose control).
  • ACE inhibitors or ARBs (monitor renal function and electrolytes).

Frequently Asked Questions

Glimepirid Bluefish contains glimepiride, a sulfonylurea class medication used to lower blood glucose in type 2 diabetes.

Glimepiride stimulates insulin release from pancreatic beta cells by closing ATP‑sensitive potassium channels, leading to cell depolarization and calcium‑mediated insulin secretion.

Glimepirid Bluefish is an oral tablet that can be taken with or without meals, but consistent timing with respect to meals helps maintain stable glucose control.

Yes, glimepiride is often combined with metformin when metformin alone does not achieve target glycemic control, under physician supervision.

Common side effects include hypoglycemia, weight gain, nausea, headache, dizziness, and mild skin rash.

Medical attention is needed for severe hypoglycemia, signs of an allergic reaction (such as swelling or difficulty breathing), or unexplained jaundice.

Elderly patients may have increased sensitivity to hypoglycemia and should be monitored closely, with dose adjustments made as needed.

Avoid using other sulfonylureas, insulin secretagogues, strong CYP2C9 inhibitors, and high‑dose salicylates due to heightened risk of low blood sugar.

Beta‑blockers may mask typical hypoglycemia symptoms such as rapid heartbeat, so patients on both should monitor glucose levels closely.

The safety of glimepiride during pregnancy has not been established; it should only be used if the potential benefit justifies the potential risk, under medical guidance.

Patients should follow their healthcare provider’s schedule, typically checking fasting and post‑prandial glucose levels daily or as directed.

If a dose is missed, take it as soon as remembered unless it is near the time of the next scheduled dose; do not double the dose.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Glimepiride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT